Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia

Title
Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia
Authors
Keywords
Alemtuzumab, Ibrutinib, Idelalisib, Obinutuzumab, Ofatumumab, Rituximab
Journal
SEMINARS IN ONCOLOGY
Volume 43, Issue 2, Pages 280-290
Publisher
Elsevier BV
Online
2016-02-09
DOI
10.1053/j.seminoncol.2016.02.010

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started